Cytek Biosciences (CTKB) Revenue Growth (3y) (2023 - 2026)
Cytek Biosciences (CTKB) Revenue Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.61 Bn | 175.32 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 108.22 Bn | 99.00 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.29 Bn | 66.84 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 28.31 Bn | 27.19 Bn | 750.30 Mn | 17.14% |
| 7 | GE HealthCare Technologies | 28.03 Bn | 25.75 Bn | 1.98 Bn | 2.92% |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 24.04 Bn | 20.91 Bn | 2.07 Bn | 0.73% |
| 10 | Cytek Biosciences | 566.95 Mn | 501.25 Mn | 21.25 Mn | 5.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.97% |
| Dec 31, 2025 | 8.73% |
| Sep 30, 2025 | 8.91% |
| Jun 30, 2025 | 4.33% |
| Mar 31, 2025 | 5.74% |
| Dec 31, 2024 | 13.90% |
| Sep 30, 2024 | 14.42% |
| Jun 30, 2024 | 15.31% |
| Mar 31, 2024 | 22.72% |
| Dec 31, 2023 | 23.90% |
| Sep 30, 2023 | 24.13% |
| Jun 30, 2023 | 37.45% |